fda drug shortage list semaglutide status january 2025 Federal judge upholds FDA's removal of Ozempic, Wegovy from GLP-1 No Longer on FDA's – Compounded Semaglutide: Legal & Safe

No PBS listing for Mounjaro (tirzepatide) in type 2 diabetes. Eli Lilly and Company

Chronic Weight Management: Acts as a highly effective, long-term intervention for adults with obesity (BMI 30) or overweight profiles (BMI 27) accompanied by weight-related health conditions

GH releasing peptides and their role in endocrinology

A hyper-responsive immune system explains flu-like symptoms

In another recent study, researchers found that people taking semaglutide had a higher risk of developing a serious eye condition called nonarteritic anterior ischemic optic neuropathy, which can cause sudden vision loss

10.1016/S2213-8587(19)30249-9 54